ReviewTherapeutics and clinical risk management2022
Diagnosis and Management of Genetic Causes of Middle Aortic Syndrome in Children: A Comprehensive Literature Review.
Review in Therapeutics and clinical risk management, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- The Hidden Constriction: Middle Aortic Syndrome Presenting as Acute Systolic Heart Failure in a 7-Month-Old Infant.CASE (Philadelphia, Pa.) · 2026Article
- Intestinal obstruction associated with middle aortic syndrome: A case report.The Journal of international medical research · 2026Article
- Surgical and Histopathologic Insights Into Mid-Aortic Syndrome: A Case Report.Case reports in surgery · 2026Article
- Long Segment Coarctation of the Abdominal Aorta in a 12-Year-Old Patient: A Case Report.Cureus · 2025Article
- Kidneys in Children with Tuberous Sclerosis Complex-An Up-to-Date Review.Journal of clinical medicine · 2025Review
- Parallel endograft repair of an aortic anastomotic pseudoaneurysm in a patient with middle aortic syndrome.Journal of vascular surgery cases and innovative techniques · 2025Article
- A Rare Clinical Presentation of Pediatric Hypertension due to Unilateral Renal Artery Stenosis with the Middle Aortic Syndrome.Journal of pharmacy & bioallied sciences · 2024Article
- A rare middle aortic syndrome with celiac trunk, superior mesenteric and bilateral renal artery involvement.Heliyon · 2023Article
- Hypertension in the Neonatal Intensive Care Unit (NICU): A Case of Mid-Aortic Syndrome.Cureus · 2023Article
- Computed tomography for aortic assessment in children.Pediatric radiology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Middle aortic syndrome (MAS) is a rare vascular disease representing an important cause of severe hypertension in children. MAS is characterized by segmental or diffuse narrowing of the abdominal and/or distal descending aorta with involvement of the renal and visceral branches. Most cases of MAS are idiopathic, but MAS may occur in genetic and acquired disorders. The most common genetic causes of MAS are neurofibromatosis type I, Williams syndrome, Alagille syndrome, tuberous sclerosis and mucopolysaccharidosis. This review article discusses the pathophysiological aspects, distinctive associated features, and management of genetic forms of MAS in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.